Related Experiment Video
Updated: Aug 23, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
Malignant Melanotic Nerve Sheath Tumor
J C Benson1, M D Marais2, P M Flanigan3
1From the Department of Radiology (J.C.B., M.D.M.) benson.john3@mayo.edu.
Malignant melanotic nerve sheath tumors are rare, aggressive spinal nerve tumors. Early identification and distinct management are vital due to overlapping imaging features with benign tumors.
Area of Science:
- Oncology
- Radiology
- Pathology
Background:
- Malignant melanotic nerve sheath tumors (MMNSTs) are rare, pigmented Schwann cell-origin tumors.
- They constitute less than 1% of all nerve sheath tumors and often occur along spinal nerves.
- Physicians may be unfamiliar with MMNSTs due to their rarity and overlapping imaging features with benign schwannomas and neurofibromas.
Purpose of the Study:
- To review the imaging appearance, histologic features, and management of MMNSTs.
- To highlight the importance of identifying MMNSTs due to their aggressive nature.
- To discuss surgical resection and therapeutic strategies for lumbar MMNSTs.
Main Methods:
- Radiology-pathology review.
- Case study of a patient with a lumbar MMNST.
- Discussion of imaging findings, histologic characteristics, surgical techniques, and treatment options.
Main Results:
- MMNSTs present imaging features that can overlap with benign nerve sheath tumors.
- These tumors are aggressive and require management distinct from benign counterparts.
- Optimal treatment involves surgical resection and tailored therapeutic strategies.
Conclusions:
- Accurate identification of MMNSTs is critical for appropriate patient management.
- The aggressive behavior of MMNSTs necessitates prompt and specialized therapeutic interventions.
- This review provides insights into the diagnosis and treatment of these uncommon tumors.
More Related Videos
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
07:10Orthotopic Xenografting of Human Luciferase-Tagged Malignant Peripheral Nerve Sheath Tumor Cells for in vivo Testing of Candidate Therapeutic Agents
Published on: March 7, 2011
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Nervous Tissue: Myelin
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...